Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Epithelial-To-Mesenchymal Transition in Thyroid Cancer: A Comprehensive Review Publisher Pubmed



Shakib H1 ; Rajabi S2 ; Dehghan MH3 ; Mashayekhi FJ4 ; Safarialighiarloo N5 ; Hedayati M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Biochemistry Department, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
  4. 4. Department of Biochemistry and Genetics, Arak University of Medical Sciences, Arak, Iran
  5. 5. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran

Source: Endocrine Published:2019


Abstract

The Metastatic progression of solid tumors, such as thyroid cancer is a complex process which involves various factors. Current understanding on the role of epithelial–mesenchymal transition (EMT) in thyroid carcinomas suggests that EMT is implicated in the progression from follicular thyroid cancer (FTC) and papillary thyroid cancer (PTC) to poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid cancer (ATC). According to the literature, the initiation of the EMT program in thyroid epithelial cells elevates the number of stem cells, which contribute to recurrent and metastatic diseases. The EMT process is orchestrated by a complex network of transcription factors, growth factors, signaling cascades, epigenetic modulations, and the tumor milieu. These factors have been shown to be dysregulated in thyroid carcinomas. Therefore, molecular interferences restoring the expression of tumor suppressors, or thwarting overexpressed oncogenes is a hopeful therapeutic method to improve the treatment of progressive diseases. In this review, we summarize the recent findings on EMT in thyroid cancer focusing on the main role-players and regulators of this process in thyroid tumors. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
Other Related Docs
11. Tumor Immunology, Clinical Immunology (2022)
15. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
17. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
31. Epigenetic of Retinoic Acid Receptor ß2 Gene in Breast Cancer, Epigenetics Territory and Cancer (2015)
32. Autophagy in Cancers Including Brain Tumors: Role of Micrornas, Cell Communication and Signaling (2020)
36. Functions of the Snai Family in Chondrocyte-To-Osteocyte Development, Annals of the New York Academy of Sciences (2021)
38. A Review on the Molecular Pathology of Epithelial Thyroid Tumors, Journal of Isfahan Medical School (2018)